Anavex Life Sciences Corp (AVXL)
4.40
+0.92%
Anavex Life Sciences Corp (AVXL) is currently trading at $4.40. This represents a gain of 0.92% from the previous session. With a market capitalization of $0.41B, AVXL is a key component of the Health Care sector. Investors looking to trade AVXL should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade AVXL commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Anavex Life Sciences Corp (AVXL) shows a bullish trend. Analysts are watching the 4.70 level closely.
Fundamentals
Mkt Cap0.41B
P/E Ratio0.0000
Volume1,189,367
60-Day Technical Chart
Advanced Charting
Need more indicators for AVXL? Use the world's #1 platform.
Open AVXL on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $4
| Metric |
AVXL +0.92% |
UWMC -8.77% |
PTON +1.98% |
HTZ -0.45% |
|---|---|---|---|---|
| Price | $4.40 | $4.16 | $4.12 | $4.42 |
| Mkt Cap | $0.41B | $6.66B | $1.75B | $1.37B |
| - | View → | View → | View → |
Latest Headlines
Alzheimer’s treatment developer Anavex to speak at TD Cowen health conference
Stock Titan • Feb 25, 2026
Is Anavex Life Sciences (AVXL) Stock Outpacing Its Medical Peers This Year?
Yahoo Finance • Feb 12, 2026
Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update
Anavex Life Sciences • Nov 25, 2025
CEO running 85 hospitals joins Alzheimer drug developer's board
Stock Titan • Feb 23, 2026
ANAVEX LIFE SCIENCES Earnings Preview: Recent $AVXL Insider Trading, Hedge Fund Activity, and More
Quiver Quantitative • Nov 23, 2025
● Gemini Agentic AI Analyst Insight for AVXL
Market Education
- Canadian ETF Uptrend Pivot Dec 10, 2023
- AI and the Stock Market: How Artificial Intelligence Is Driving a New Bull Run Sep 26, 2025
- Understanding Hedge Fund Alpha and Beta: A Guide for New Investors Jun 2, 2024
External Research